BIOMAT Database Logo BIOMAT Database Logo

Toxic effects of interferon administered intrathecally. 1983

J Ruutiainen, and M Panelius, and K Cantell

UI MeSH Term Description Entries
D007278 Injections, Spinal Introduction of therapeutic agents into the spinal region using a needle and syringe. Injections, Intraspinal,Injections, Intrathecal,Intraspinal Injections,Intrathecal Injections,Spinal Injections,Injection, Intraspinal,Injection, Intrathecal,Injection, Spinal,Intraspinal Injection,Intrathecal Injection,Spinal Injection
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D008297 Male Males
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

J Ruutiainen, and M Panelius, and K Cantell
[The effects of intrathecally administered human lymphoblastoid interferon on subacute sclerosing panencephalitis].
September 1985, No to hattatsu = Brain and development,
J Ruutiainen, and M Panelius, and K Cantell
[Neurotropic effects of tranquilizers administered intrathecally].
January 1988, Farmakologiia i toksikologiia,
J Ruutiainen, and M Panelius, and K Cantell
The spread and side-effects of intrathecally administered bupivacaine.
October 1999, Anaesthesia,
J Ruutiainen, and M Panelius, and K Cantell
Antihyperalgesic effects of intrathecally administered magnesium sulfate in rats.
February 2000, Pain,
J Ruutiainen, and M Panelius, and K Cantell
Antinociceptive effects of intrathecally administered endothelin-1 in mice.
April 1993, Neuroscience letters,
J Ruutiainen, and M Panelius, and K Cantell
Antinociceptive effects of intrathecally administered 2-methylserotonin in developing rats.
January 1997, Brain research. Developmental brain research,
J Ruutiainen, and M Panelius, and K Cantell
Antinociceptive effects of nociceptin/orphanin FQ administered intrathecally in monkeys.
May 2009, The journal of pain,
J Ruutiainen, and M Panelius, and K Cantell
Effects of diabetes on the antinociceptive effects of intrathecally administered endothelin-1.
February 1993, Research communications in chemical pathology and pharmacology,
J Ruutiainen, and M Panelius, and K Cantell
Antinociceptive effect of intrathecally administered serotonin.
September 1977, Anesthesiology,
J Ruutiainen, and M Panelius, and K Cantell
Pharmacokinetics of intrathecally administered amphotericin B.
June 1969, The American review of respiratory disease,
Copied contents to your clipboard!